Browsing by Author Sandercock, Peter A G

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2005Alteplase and ischaemic stroke: have new reviews of old data helped?Lindley, Richard; Sandercock, Peter A G; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Alteplase and ischaemic stroke: have new reviews of old data helped?, Lancet Neurology, vol.4,(4),2005,pp 249-253
2015Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke TrialLindley, Richard; Blackwell, Lisa; Cohen, Geoff; Murray, Gordon; Sandercock, Peter A G; Wardlaw, Joanna; Whiteley, Will; Western Clinical School: Medicine (Westmead)Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial, Stroke, vol.46, 3, 2015,pp 746-756
2012The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialLindley, Richard; Cohen, Geoff; Czlonkowska, Anna; Dennis, Martin; et al, Various; Innes, Karen; Kobayashi, Adam; Krause, Martin; Murray, Gordon; Ricci, Stefano; Sandercock, Peter A G; Venables, Graham; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, The Lancet, vol.379, 9834, 2012,pp 2352-2363
2015Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic StrokeLindley, Richard; Mair, Grant; Sandercock, Peter A G; von Kummer, Rüdiger; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic Stroke, PloS One, vol.10, 17, 2015,pp 1-12
2006Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial.Lindley, Richard; IST-3, C l; Kane, Ingrid; Lewis, Steff; Sandercock, Peter A G; Western Clinical School: Medicine (Westmead)Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial., Cerebrovascular Diseases, vol.21,(5-6),2006,pp 348-352
2015Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic strokeLindley, Richard; Carpenter, Trevor; Chappell, Francesca; Cohen, Geoff; Kobayashi, Adam; Murray, Veronica; Parsons, Mark; Peeters, Andre; Sandercock, Peter A G; von Kummer, Rudiger; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke, International Journal of Stroke, vol.10, 6, 2015,pp 956-968
2012Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisLindley, Richard; Berge, Eivind; Cohen, Geoff; del Zoppo, Gregory; Murray, Veronica; Sandercock, Peter A G; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis, The Lancet, vol.379, 9834, 2012,pp 2364-2372
2015Sensitivity and Specificity of the Hyperdense Artery Sign for Arterial Obstruction in Acute Ischemic StrokeLindley, Richard; Boyd, Elena; Chappell, Francesca; Mair, Grant; Sandercock, Peter A G; von Kummer, Rüdiger; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Sensitivity and Specificity of the Hyperdense Artery Sign for Arterial Obstruction in Acute Ischemic Stroke, Stroke, vol.46, 1, 2015,pp 102-107
2014Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trialLindley, Richard; Cohen, Geoff; Murray, Gordon D; Sandercock, Peter A G; Thompson, Douglas; Wardlaw, Joanna; Whiteley, William; Western Clinical School: Medicine (Westmead)Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trial, Stroke, vol.45, 4, 2014,pp 1000-1006
2006Third International Stroke TrialLindley, Richard; IST-3 Collaborative Group, etc; Sandercock, Peter A G; Wardlaw, Joanna; Whiteley, William; Western Clinical School: Medicine (Westmead)Third International Stroke Trial, International Journal of Stroke, vol.1, 3, 2006,pp 172-176
2008The third international stroke trial (IST-3) of thrombolysis for acute ischaemic strokeLindley, Richard; Berge, Eivind; Czlonkowska, Anna; Dennis, Martin S.; et al, Not Known; Kobayashi, Adam; Lewis, Steff; Murray, Veronica; Sandercock, Peter A G; Slot, Karsten Bruins; Venables, Graham; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke, Trials, vol.9,(37),2008,pp 37-1-37-17
2009The Third International Stroke Trial: Thrombolysis (IST-3) in Poland: are we recruiting the right patients?Lindley, Richard; Barañska-Gieruszczak, Maria; Czlonkowska, Anna; Kobayashi, Adam; Lewis, Steff; Sandercock, Peter A G; Western Clinical School: Medicine (Westmead)The Third International Stroke Trial: Thrombolysis (IST-3) in Poland: are we recruiting the right patients?, Neurologia i Neurochirurgia Polska, vol.43, 3, 2009,pp 228-235